WallStreetZenWallStreetZen

NASDAQ: AVXL
Anavex Life Sciences Corp Stock Forecast, Predictions & Price Target

Analyst price target for AVXL

Based on 1 analyst offering 12 month price targets for Anavex Life Sciences Corp.
Min Forecast
$40.00+1,079.94%
Avg Forecast
$40.00+1,079.94%
Max Forecast
$40.00+1,079.94%

Should I buy or sell AVXL stock?

Based on 1 analyst offering ratings for Anavex Life Sciences Corp.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AVXL stock forecasts and price targets.

AVXL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-01-03

1 of 1

Forecast return on equity

Is AVXL forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.16%

Forecast return on assets

Is AVXL forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

AVXL revenue forecast

What is AVXL's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$28.2M
Avg 2 year Forecast
$43.1M
Avg 3 year Forecast
$1.8B

AVXL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AVXL$3.39$40.00+1,079.94%Buy
AKBA$1.33$5.00+275.94%Strong Buy
NBTX$5.91$11.00+86.13%Buy
VRCA$6.65$10.33+55.38%Strong Buy
GLUE$5.45$11.00+101.83%Buy

Anavex Life Sciences Stock Forecast FAQ

Is Anavex Life Sciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: AVXL) stock is to Buy AVXL stock.

Out of 1 analyst, 0 (0%) are recommending AVXL as a Strong Buy, 1 (100%) are recommending AVXL as a Buy, 0 (0%) are recommending AVXL as a Hold, 0 (0%) are recommending AVXL as a Sell, and 0 (0%) are recommending AVXL as a Strong Sell.

If you're new to stock investing, here's how to buy Anavex Life Sciences stock.

What is AVXL's revenue growth forecast for 2024-2026?

(NASDAQ: AVXL) Anavex Life Sciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Anavex Life Sciences's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast AVXL's revenue for 2024 to be $2,314,751,685, with the lowest AVXL revenue forecast at $2,314,751,685, and the highest AVXL revenue forecast at $2,314,751,685. On average, 1 Wall Street analysts forecast AVXL's revenue for 2025 to be $3,541,512,599, with the lowest AVXL revenue forecast at $3,541,512,599, and the highest AVXL revenue forecast at $3,541,512,599.

In 2026, AVXL is forecast to generate $147,625,977,901 in revenue, with the lowest revenue forecast at $147,625,977,901 and the highest revenue forecast at $147,625,977,901.

What is AVXL's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: AVXL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is AVXL's Price Target?

According to 1 Wall Street analyst that have issued a 1 year AVXL price target, the average AVXL price target is $40.00, with the highest AVXL stock price forecast at $40.00 and the lowest AVXL stock price forecast at $40.00.

The Wall Street analyst predicted that Anavex Life Sciences's share price could reach $40.00 by Jan 3, 2025. The average Anavex Life Sciences stock price prediction forecasts a potential upside of 1,079.94% from the current AVXL share price of $3.39.

What is AVXL's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: AVXL) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.